BIOTECH
BIOTECH
Doron Therapeutics Announces Positive End-of-Phase 2 and Initial RMAT Meeting With FDA for MOTYS (PTP-001) in the Treatment of Knee Osteoarthritis
CHAPEL HILL, NORTH CAROLINA / ACCESS Newswire / May 20, 2025 / Doron Therapeutics, a clinical-stage biotechnology company...
Read moreBIOTECH
Azalea Vision Raises €9 Million in First Closing of Series A to Further Develop Intelligent Connected Vision Platform
GHENT, Belgium–(BUSINESS WIRE)–Azalea (A-zuh-lay-ah) Vision, a HealthTech company engineering the future of sight, today announced the...
Read moreBIOTECH
Cadwell Makes a Strategic Investment in Seer Medical to Expand Home-Based Epilepsy Diagnostics
KENNEWICK, Wash., April 15, 2025 /PRNewswire/ — Cadwell Industries, Inc., a global leader in neurodiagnostic, neuromonitoring, and sleep...
Read moreBIOTECH
PulseSight Therapeutics Announces First Close of its Series A Financing to Fund Clinical Development of PST-611 in dry AMD
PARIS, Feb. 13, 2025 (GLOBE NEWSWIRE) — PulseSight Therapeutics SAS, an ophthalmology biotech company developing...
Read moreBIOTECH
RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases
Company focused on editing the human leukocyte antigen (HLA) to transform autoimmunity Lead program, RG0401,...
Read more